Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free THMO Stock Alerts

ThermoGenesis (THMO) Competitors

ThermoGenesis logo
Compare

THMO vs. HTGMQ, PRENW, SMAPW, TT, and KEYS

Should you buy ThermoGenesis stock or one of its competitors? MarketBeat compares ThermoGenesis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ThermoGenesis include HTG Molecular Diagnostics (HTGMQ), Prenetics Global (PRENW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry.

How does ThermoGenesis compare to HTG Molecular Diagnostics?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

HTG Molecular Diagnostics has a beta of 3.06, indicating that its stock price is 206% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

5.8% of ThermoGenesis shares are held by institutional investors. 2.6% of HTG Molecular Diagnostics shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
ThermoGenesis Neutral

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 7 factors compared between the two stocks.

How does ThermoGenesis compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Prenetics Global had 2 more articles in the media than ThermoGenesis. MarketBeat recorded 2 mentions for Prenetics Global and 0 mentions for ThermoGenesis. Prenetics Global's average media sentiment score of 0.43 beat ThermoGenesis' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company Overall Sentiment
Prenetics Global Neutral
ThermoGenesis Neutral

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
ThermoGenesis N/A N/A N/A

Prenetics Global has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$120.07MN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Summary

Prenetics Global beats ThermoGenesis on 3 of the 5 factors compared between the two stocks.

How does ThermoGenesis compare to SportsMap Tech Acquisition?

SportsMap Tech Acquisition (NASDAQ:SMAPW) and ThermoGenesis (NASDAQ:THMO) are both measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

SportsMap Tech Acquisition has higher earnings, but lower revenue than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SportsMap Tech AcquisitionN/AN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

In the previous week, SportsMap Tech Acquisition's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
SportsMap Tech Acquisition Neutral
ThermoGenesis Neutral

Company Net Margins Return on Equity Return on Assets
SportsMap Tech AcquisitionN/A N/A N/A
ThermoGenesis N/A N/A N/A

Summary

ThermoGenesis beats SportsMap Tech Acquisition on 3 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Trane Technologies?

ThermoGenesis (NASDAQ:THMO) and Trane Technologies (NYSE:TT) are both measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Trane Technologies has higher revenue and earnings than ThermoGenesis. ThermoGenesis is trading at a lower price-to-earnings ratio than Trane Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Trane Technologies$21.32B4.99$2.92B$12.9337.21

ThermoGenesis has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market. Comparatively, Trane Technologies has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

Trane Technologies has a consensus target price of $516.67, suggesting a potential upside of 7.40%. Given Trane Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Trane Technologies is more favorable than ThermoGenesis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ThermoGenesis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Trane Technologies
1 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.76

5.8% of ThermoGenesis shares are held by institutional investors. Comparatively, 83.0% of Trane Technologies shares are held by institutional investors. 78.0% of ThermoGenesis shares are held by insiders. Comparatively, 0.4% of Trane Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Trane Technologies had 26 more articles in the media than ThermoGenesis. MarketBeat recorded 26 mentions for Trane Technologies and 0 mentions for ThermoGenesis. Trane Technologies' average media sentiment score of 1.34 beat ThermoGenesis' score of 0.00 indicating that Trane Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
ThermoGenesis Neutral
Trane Technologies Positive

Trane Technologies has a net margin of 13.41% compared to ThermoGenesis' net margin of 0.00%. Trane Technologies' return on equity of 35.55% beat ThermoGenesis' return on equity.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Trane Technologies 13.41%35.55%13.73%

Summary

Trane Technologies beats ThermoGenesis on 15 of the 16 factors compared between the two stocks.

How does ThermoGenesis compare to Keysight Technologies?

ThermoGenesis (NASDAQ:THMO) and Keysight Technologies (NYSE:KEYS) are both measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Keysight Technologies has higher revenue and earnings than ThermoGenesis. ThermoGenesis is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Keysight Technologies$5.38B10.15$850M$6.0852.50

Keysight Technologies has a consensus price target of $371.92, indicating a potential upside of 16.51%. Given Keysight Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Keysight Technologies is more favorable than ThermoGenesis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ThermoGenesis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Keysight Technologies
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86

In the previous week, Keysight Technologies had 25 more articles in the media than ThermoGenesis. MarketBeat recorded 25 mentions for Keysight Technologies and 0 mentions for ThermoGenesis. Keysight Technologies' average media sentiment score of 1.37 beat ThermoGenesis' score of 0.00 indicating that Keysight Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
ThermoGenesis Neutral
Keysight Technologies Positive

ThermoGenesis has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, Keysight Technologies has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market.

Keysight Technologies has a net margin of 17.25% compared to ThermoGenesis' net margin of 0.00%. Keysight Technologies' return on equity of 21.58% beat ThermoGenesis' return on equity.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Keysight Technologies 17.25%21.58%11.51%

5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 84.6% of Keysight Technologies shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 0.4% of Keysight Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Keysight Technologies beats ThermoGenesis on 15 of the 16 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

Export
MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1K$7.06B$12.20B
Dividend YieldN/AN/A2.67%9.41%
P/E Ratio0.00N/A27.1423.63
Price / SalesN/A0.00582.30111.98
Price / CashN/AN/A49.8158.78
Price / BookN/AN/A10.286.01
Net Income-$17.98M-$17.98M$3.60B$331.99M

ThermoGenesis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
PRENW
Prenetics Global
N/A$0.02
+14.3%		N/A-64.7%$0.00$120.07MN/A1
SMAPW
SportsMap Tech Acquisition
N/A$0.03
flat		N/A-24.2%$0.00N/AN/AN/A
TT
Trane Technologies
4.4625 of 5 stars		$469.59
-1.1%		$516.67
+10.0%		+1.8%$105.00B$21.32B36.3244,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:THMO) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
Oxford Club Analyst’s Urgent AI Warning
Alexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...
The Oxford Club | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
The 90%-off options that empty accounts
A call that cost $3.00 last month now trades for $0.30 - a 90% discount that looks tempting. It's not a bar...
Profits Run | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel